Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Cooper Companies (COO) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical Instruments & SuppliesCOO

Latest price · Nov 20, 2026 $59.64 -1.1% on the day · -16.1% over 12 months 52-week range $53.27 – $84.32
Get COO alerts
Open-market purchases7 insiders$3.2M · last 12 months
Insiders selling0last 12 months
Reported sales$0last 12 months
In 15 seconds

Insiders put their own money in: $3.2M of open-market buys. See how similar setups did below.

Past insider buys here: 0 of 5 beat the S&P 500 over the next 90 days. See each one ↓

Label: Strong buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • 90-day result for Lawrence Erik Kurzius's $539K buy: in on Dec 14, 2026. 3 more buys pending. See the 7- and 30-day results ↓
  • Next earnings expected around Dec 15, 2026 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Purchase Lawrence Erik Kurzius, Director bought 10,000 shares at $54.93 ($549K).

Trade date
Sep 16, 2026
Disclosed to the SEC
Sep 17, 2026
Type
Open-market purchase (code P)

Lawrence Erik Kurzius's record since 2025: 1 of 2 past buys beat the S&P 500 over 90 days (small sample).

Read the original SEC filing ↗All COO insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

COO insider transactions (Form 4)

Open-market purchases and sales. 36 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Sep 17SEC Lawrence Erik KurziusDirectorPast buys 1/2 beat S&P Buy 10,00031,099 held (+47%) $54.93 $549K +8.6% 56
Sep 15SEC Lawrence Erik KurziusDirectorStake +90%Past buys 1/2 beat S&P Buy 10,00021,099 held (+90%) $53.91 $539K +10.6% 56
Sep 15SEC Walter M. Rosebrough Jr.DirectorFirst buyStake +70% Buy 7,00017,000 held (+70%) $54.11 $379K +10.2% —
Sep 15SEC Paul A. KeelDirectorFirst buyNew position Buy 4,701new position $53.18 $250K +12.1% —
Sep 15SEC Walter M. Rosebrough Jr.DirectorFirst buy Buy 3,00020,000 held (+18%) $54.29 $163K +9.9% —
Dec 23SEC Cynthia L. LuccheseDirectorFirst buy Buy 1,7849,445 held (+23%) $84.06 $150K -29.1% 42
Dec 19SEC Maria RivasDirectorFirst buy Buy 1,00011,141 held (+10%) $82.13 $82K -27.4% —
Dec 17SEC Lawrence Erik KurziusDirectorPast buys 1/2 beat S&P Buy 2,0007,777 held (+35%) $82.50 $165K -27.7% 56
Dec 16SEC Albert G. White IIICEO, PresidentPast buys 2/3 beat S&P Buy 10,000236,151 held (+4%) $80.80 $808K -26.2% —
Dec 16SEC Holly R. SheffieldPresidentFirst buy in 5 yrsPast buys 2/3 beat S&P Buy 1,23039,052 held (+3%) $80.75 $99K -26.1% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for COO's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with COO in the Research Lab

Pre-set to COO's latest insider buy of $10K or more (Sep 17, 2026: Lawrence Erik Kurzius, Paul A. Keel, Walter M. Rosebrough Jr., $1.9M). Tap to change anything.

All tools →

Share price and insider trades

COO closeInsider buyInsider sale
5060708090DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2025-12-04EEarnings release filed 2026-03-05EEarnings release filed 2026-06-04EEarnings release filed 2026-09-09Bought $82,130 on 2025-12-18 · Maria RivasBought $149,963 on 2025-12-22 · Cynthia L. LuccheseBought $165,000 on 2025-12-17 · Lawrence Erik KurziusBought $549,320 on 2026-09-16 · Lawrence Erik KurziusBought $628,770 on 2026-09-11 · Paul A. Keel, Walter M. Rosebrough Jr.Bought $702,020 on 2026-09-14 · Lawrence Erik Kurzius, Walter M. Rosebrough Jr.Bought $907,322 on 2025-12-16 · Albert G. White III, Holly R. Sheffield
Bought, 12 months$3.2M
Sold, 12 months$0
Insiders buying7
Insiders selling0

Cooper Companies insider trading at a glance (Nov 20, 2026): in the past 12 months, 7 insiders bought $3.2M and 0 sold $0 of COO stock on the open market, including a cluster buy that began Sep 11, 2026; P/E 21.3 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

COO insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.3M bought (5 trades)$1.3MQ4 2025Q1 2026Q2 2026Q3 2026: $1.9M bought (5 trades)$1.9MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$1.9M5—0
Q2 2026—0—0
Q1 2026—0—0
Q4 2025$1.3M5—0

Valuation, profit and volume

P/E (trailing)21.3Sector median 25.0
Market value$11.81BMedical Instruments & Supplies
Profit margin13.5%Revenue growth +0.6%
Volume vs. 50-day0.4×Last 5 sessions
Insiders' paper profit−$160KOn all tracked purchases -5.0%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 7 Cooper Companies (The) insiders reported open-market purchases totaling $3.2M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Sep 11, 2026, when 3 insiders bought a combined $1.9M. Among insiders with enough purchase history to measure, Lawrence Erik Kurzius (Director) has the highest Insider Score at 56.

COO earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Sep 9, 2026 -10.7% None -20.0%S&P -1.1% +0.4%
Jun 4, 2026 -1.8% None +11.6%S&P -2.2% +10.2%
Mar 5, 2026 +0.0% None -6.6%S&P -1.9% -8.3%
Dec 4, 2025 +5.2% None +7.1%S&P +0.3% -0.4%
Aug 27, 2025 +3.9% None -12.3%S&P +0.6% +4.6%
May 29, 2025 -2.0% None -14.8%S&P +0.3% +4.2%
Mar 6, 2025 +4.6% None -6.9%S&P -1.2% -13.2%
Dec 5, 2024 +6.0% None -6.0%S&P +0.0% -7.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

COO news sentiment trend

Weekly headline tone (positive minus negative headlines) over 13 weeks. Green dots mark weeks with insider buying.

Not enough news
Aug 22Week of 2026-09-05: 1 headlines, 1 positive, 0 negativeInsider buying that weekWeek of 2026-09-12: 1 headlines, 1 positive, 0 negativeInsider buying that weekSep 12Oct 3Oct 24Nov 14
Last 30 days: 0 headlines, 0 positive, 0 negative

Tone is scored from headline wording only. It describes the news, not where the stock is going.

COO short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 24% of volume sold short2026-08-27: 45% of volume sold short2026-08-28: 34% of volume sold short2026-08-31: 43% of volume sold short2026-09-01: 34% of volume sold short2026-09-02: 45% of volume sold short2026-09-03: 78% of volume sold short2026-09-04: 51% of volume sold short2026-09-08: 68% of volume sold short2026-09-09: 61% of volume sold short2026-09-10: 33% of volume sold short2026-09-11: 16% of volume sold short2026-09-14: 23% of volume sold short2026-09-15: 17% of volume sold short2026-09-16: 12% of volume sold short2026-09-17: 12% of volume sold short2026-09-18: 16% of volume sold short2026-09-21: 22% of volume sold short2026-09-22: 20% of volume sold short2026-09-23: 26% of volume sold short2026-09-24: 26% of volume sold short2026-09-25: 16% of volume sold short2026-09-28: 14% of volume sold short2026-09-29: 14% of volume sold short2026-09-30: 16% of volume sold short2026-10-01: 39% of volume sold short2026-10-02: 38% of volume sold short2026-10-05: 39% of volume sold short2026-10-06: 29% of volume sold short2026-10-07: 42% of volume sold short2026-10-08: 41% of volume sold short2026-10-09: 33% of volume sold short2026-10-12: 33% of volume sold short2026-10-13: 24% of volume sold short2026-10-14: 12% of volume sold short2026-10-15: 17% of volume sold short2026-10-16: 40% of volume sold short2026-10-19: 33% of volume sold short2026-10-20: 36% of volume sold short2026-10-21: 28% of volume sold short2026-10-22: 18% of volume sold short2026-10-23: 33% of volume sold short2026-10-26: 33% of volume sold short2026-10-27: 25% of volume sold short2026-10-28: 50% of volume sold short2026-10-29: 44% of volume sold short2026-10-30: 13% of volume sold short2026-11-02: 35% of volume sold short2026-11-03: 36% of volume sold short2026-11-04: 23% of volume sold short2026-11-05: 45% of volume sold short2026-11-06: 36% of volume sold short2026-11-09: 42% of volume sold short2026-11-10: 36% of volume sold short2026-11-11: 23% of volume sold short2026-11-12: 37% of volume sold short2026-11-13: 49% of volume sold short2026-11-16: 50% of volume sold short2026-11-17: 38% of volume sold short2026-11-18: 23% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 23%20-day average: 30%Prior 2 months: 29%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded COO

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 -14.5%

COO stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after COO insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Sep 17, 2026Lawrence Erik KurziusDirector$549K +3.0%+2.1% vs S&P+8.1%+7.4% vs S&Ppending
Sep 15, 2026Lawrence Erik KurziusDirector$539K +3.8%+1.4% vs S&P+7.8%+5.6% vs S&Ppending
Sep 15, 2026Walter M. Rosebrough Jr.Director$542K +3.8%+1.4% vs S&P+7.8%+5.6% vs S&Ppending
Sep 15, 2026Paul A. KeelDirector$250K +3.8%+1.4% vs S&P+7.8%+5.6% vs S&Ppending
Dec 23, 2025Cynthia L. LuccheseDirector$150K -0.5%-0.4% vs S&P-0.1%-0.2% vs S&P-15.3%-10.8% vs S&P
Dec 19, 2025Maria RivasDirector$82K -0.2%-1.6% vs S&P-2.6%-2.1% vs S&P-14.5%-11.5% vs S&P
Dec 17, 2025Lawrence Erik KurziusDirector$165K +0.1%-3.0% vs S&P-0.1%-3.5% vs S&P-12.6%-12.8% vs S&P
Dec 16, 2025Albert G. White IIICEO, President$808K +2.3%+0.6% vs S&P+1.6%-0.7% vs S&P-12.3%-11.2% vs S&P
Dec 16, 2025Holly R. SheffieldPresident$99K +2.3%+0.6% vs S&P+1.6%-0.7% vs S&P-12.3%-11.2% vs S&P

Insiders at Cooper Companies (The)

InsiderBoughtSoldLast filingPast buys beat S&PScore
Lawrence Erik KurziusDirector $1.3M — Sep 17, 2026 1 of 2 56
Albert G. White IIICEO, President $808K — Jan 12, 2026 2 of 3 —
Walter M. Rosebrough Jr.Director $542K — Sep 15, 2026 — —
Paul A. KeelDirector $250K — Sep 15, 2026 — —
Cynthia L. LuccheseDirector $150K — Apr 6, 2026 0 of 1 42
Holly R. SheffieldPresident $99K — Jan 12, 2026 2 of 3 —
Maria RivasDirector $82K — Apr 6, 2026 0 of 1 —
Teresa S. MaddenDirector — — Apr 6, 2026 — —
Robert S. WeissDirector — — Apr 6, 2026 — —
Colleen JayDirector — — Apr 6, 2026 — —
Barbara CarboneDirector — — Apr 6, 2026 — —
Daniel G. McBrideCOO — — Jan 12, 2026 1 of 1 —
Brian G. AndrewsCFO — — Jan 12, 2026 1 of 1 —
Gerard H. Warner IIIPresident — — Jan 12, 2026 1 of 1 —

Board links: companies that share insiders with COO

Directors and executives who filed Form 4s for COO and another company in the last 12 months.

See the map →

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

COO stock: common questions

Are Cooper Companies (The) insiders buying COO stock?

In the past 12 months, 7 insiders reported open-market purchases of COO worth $3.2M. The latest was Director Lawrence Erik Kurzius bought $549K of COO at $54.93 — raises the stake by 47%.

Are Cooper Companies (The) insiders selling COO stock?

No. No Cooper Companies (The) insider reported an open-market sale of COO in the past 12 months.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is COO's P/E ratio?

COO trades at about 21.3 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is COO's 52-week range?

Over the past year COO has traded between $53.27 and $84.32. It last closed at $59.64 on Nov 20, 2026.